XML 56 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity - Additional Information (Detail) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
May 31, 2013
Outside Board Member [Member]
Directors
Dec. 31, 2013
Eleven Employees [Member]
Dec. 31, 2013
Eleven Employees [Member]
Employees
Feb. 28, 2013
Five Employees [Member]
Employees
Feb. 28, 2013
Five Employees [Member]
Other Than Performance Shares [Member]
Feb. 28, 2013
Five Employees [Member]
Performance Shares [Member]
Feb. 28, 2013
Seven Employees and Five Outside Board Members [Member]
Directors
Employees
Feb. 28, 2013
Seven Employees and Five Outside Board Members [Member]
Performance Shares [Member]
Apr. 30, 2014
Three Employee [Member]
Employees
Apr. 30, 2014
Three Employee [Member]
Other Than Performance Shares [Member]
Apr. 30, 2014
Six Employees And Five Outside Board Members [Member]
Directors
Employees
Jan. 31, 2014
Jonathan J. Corp [Member]
Jan. 31, 2014
Jonathan J. Corp [Member]
Common Stock [Member]
Nov. 30, 2013
Oppenheimer & Co., Inc [Member]
Common Stock [Member]
Jan. 24, 2014
Clarence E. Smith [Member]
Jan. 31, 2014
Clarence E. Smith [Member]
Nov. 30, 2013
Clarence E. Smith [Member]
Disclosure Stockholders Equity Additional Information Detail [Line Items]                                            
Common stock granted under the long term incentive bonus program                 42,000 36,000 6,000     21,000 21,000     25,000 37,500      
No of employees               11 5     7   3   6            
Share-based compensation, option vesting period           3 years       3 years 3 years 3 years     3 years 3 years            
Common stock options granted, exercise price           $ 3.00     $ 2.50     $ 2.50   $ 3.90   $ 3.80 $ 0.65          
Compensation expense amortization period                 3 years         3 years                
Common Stock Granted under Long term incentive plan     252,000   446,000 100,000 9,000         346,000 12,000     252,000            
Number of Directors           1           5       5            
Expected term           5 years           5 years       5 years            
Exercised price                                         $ 1.50 $ 1.50
Number of options exercised     163,331   30,500                             138,331 138,331  
Beneficial ownership percentage                                         5.00% 5.00%
Shares vested using fair market value             9,000 9,000                            
Total share-based compensation expense $ 284,675 $ 325,801 $ 483,216 $ 635,863       $ 25,650